NRIX
Price
$19.03
Change
+$0.10 (+0.53%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.93B
34 days until earnings call
Intraday BUY SELL Signals
VRDN
Price
$33.78
Change
+$1.79 (+5.60%)
Updated
Jan 14 closing price
Capitalization
3.22B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs VRDN

Header iconNRIX vs VRDN Comparison
Open Charts NRIX vs VRDNBanner chart's image
Nurix Therapeutics
Price$19.03
Change+$0.10 (+0.53%)
Volume$91.92K
Capitalization1.93B
Viridian Therapeutics
Price$33.78
Change+$1.79 (+5.60%)
Volume$1.56M
Capitalization3.22B
NRIX vs VRDN Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. VRDN commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (NRIX: $19.04 vs. VRDN: $33.78)
Brand notoriety: NRIX and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 59% vs. VRDN: 97%
Market capitalization -- NRIX: $1.93B vs. VRDN: $3.22B
NRIX [@Biotechnology] is valued at $1.93B. VRDN’s [@Biotechnology] market capitalization is $3.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 4 bearish.
  • VRDN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VRDN is a better buy in the short-term than NRIX.

Price Growth

NRIX (@Biotechnology) experienced а +2.97% price change this week, while VRDN (@Biotechnology) price change was +10.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 18, 2026.

VRDN is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($3.23B) has a higher market cap than NRIX($1.93B). VRDN YTD gains are higher at: 8.548 vs. NRIX (-0.211). NRIX has higher annual earnings (EBITDA): -248.7M vs. VRDN (-298.48M). VRDN has more cash in the bank: 491M vs. NRIX (429M). VRDN has less debt than NRIX: VRDN (21.6M) vs NRIX (56.5M). NRIX has higher revenues than VRDN: NRIX (83.7M) vs VRDN (70.8M).
NRIXVRDNNRIX / VRDN
Capitalization1.93B3.23B60%
EBITDA-248.7M-298.48M83%
Gain YTD-0.2118.548-2%
P/E RatioN/AN/A-
Revenue83.7M70.8M118%
Total Cash429M491M87%
Total Debt56.5M21.6M262%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXVRDN
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LBGAX42.710.01
+0.02%
ClearBridge Mid Cap Growth A
EIUTX16.14-0.02
-0.12%
Eaton Vance Dividend Builder I
PGODX82.64-0.29
-0.35%
Putnam Large Cap Growth R5
AIVEX20.96-0.09
-0.43%
American Funds International Vntg F-1
OBGIX33.39-0.17
-0.51%
Oberweis Global Opportunities Instl

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+2.99%
KYMR - NRIX
65%
Loosely correlated
+1.42%
KURA - NRIX
55%
Loosely correlated
+0.44%
XNCR - NRIX
55%
Loosely correlated
-1.62%
OCUL - NRIX
54%
Loosely correlated
-2.43%
TYRA - NRIX
53%
Loosely correlated
+0.14%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with NUVL. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+5.60%
NUVL - VRDN
57%
Loosely correlated
+6.59%
XNCR - VRDN
55%
Loosely correlated
+3.66%
SYRE - VRDN
55%
Loosely correlated
+5.17%
CLDX - VRDN
53%
Loosely correlated
+1.58%
NRIX - VRDN
49%
Loosely correlated
+0.58%
More